Data / Form D filings / ALLOCURE INC
ALLOCURE INC: Form D filings
ALLOCURE INC, a biotechnology company in Burlington, MA, filed 5 Form D notices with the SEC between 2009 and 2013. The latest, on December 23, 2013, reports $26.5 million sold of a $26.5 million offering to 5 investors.
Find out what ALLOCURE INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 25 CORPORATE DRIVE, SUITE 360, Burlington, MA, 01803
- Phone
- 1-781-425-5380
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1439955
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 23, 2013 | Amendment | $26,500,008 | $26,500,008 | $0 | 5 | Mar 29, 2012 | sec.gov |
| Apr 10, 2012 | New notice | $26,500,008 | $16,500,005 | $10,000,003 | 5 | Mar 29, 2012 | sec.gov |
| Oct 13, 2011 | New notice | $1,501,500 | $1,501,500 | $0 | 4 | Sep 30, 2011 | sec.gov |
| Nov 18, 2009 | New notice | $5,588,179 | $5,588,179 | $0 | 4 | Nov 5, 2009 | sec.gov |
| Jul 7, 2009 | New notice | $400,080 | $400,080 | $0 | 4 | Jun 25, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mette Kirstine Agger | Director | |
| John B. Wirthlin | Executive Officer | |
| Robert M Brenner | Executive Officer, Director | |
| Thomas B. Dyrberg | Director | |
| Scott Kirstine Canute | Director | |
| David Kirstine Guyer | Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
Every Form D from the week of Dec 23, 2013 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ALLOCURE INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.